Long-COVID study reveals immunological improvement two years after infection
April 18, 2024
Immune abnormalities have largely resolved at 24 months in a cohort of patients with long COVID, providing optimism that long COVID can resolve over time.
Biomarkers for long COVID that were present in patients at eight months have largely resolved by 24 months among a cohort of people who contracted COVID-19 during Australia’s first wave.
Jointly led by the Kirby Institute at UNSW Sydney and St Vincent’s Hospital Sydney and published today in Nature Communications, the research provides optimistic insights to suggest that long-COVID abnormalities can resolve over time.
Read more: Long-COVID study reveals immunological improvement two years after infection (unsw.edu.au)
Brings together the strengths of four founding organisations